Ives Jeffrey L. 4
4 · Acumen Pharmaceuticals, Inc. · Filed Jun 17, 2022
Insider Transaction Report
Form 4
Ives Jeffrey L.
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-15+25,000→ 25,000 totalExercise: $3.59Exp: 2032-06-14→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest on on the earlier of June 15, 2023 or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through each such vesting date.